Quick Answer
Cellectar Biosciences, Inc. reported Total Assets of $14.98 million for the year ending 2025.
- Cellectar Biosciences, Inc. showed a decrease of -41.2% in Total Assets from 2024 to 2025.
- This data is from Cellectar Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $8.43 million | Q3 2011: $6.99 million | Q1 2012: $8.65 million | Q2 2012: $11.85 million | Q3 2012: $10.39 million | Q1 2013: $14.31 million | Q2 2013: $12.13 million | Q3 2013: $9.65 million | Q1 2014: $8.04 million | Q2 2014: $5.89 million | Q3 2014: $15.72 million | Q1 2015: $10.91 million | Q2 2015: $8.58 million | Q3 2015: $6.46 million | Q1 2016: $5.57 million | Q2 2016: $11.38 million | Q3 2016: $9.30 million | Q1 2017: $15.30 million | Q2 2017: $12.60 million | Q3 2017: $9.87 million | Q1 2018: $9.56 million | Q2 2018: $7.00 million | Q3 2018: $19.54 million | Q1 2019: $12.55 million | Q2 2019: $19.14 million | Q3 2019: $15.66 million | Q1 2020: $8.69 million | Q2 2020: $23.85 million | Q3 2020: $20.70 million | Q1 2021: $55.06 million | Q2 2021: $47.74 million | Q3 2021: $41.95 million | Q1 2022: $31.99 million | Q2 2022: $25.89 million | Q3 2022: $19.32 million | Q1 2023: $14.84 million | Q2 2023: $6.51 million | Q3 2023: $21.55 million | Q1 2024: $42.91 million | Q2 2024: $29.38 million | Q3 2024: $37.29 million | Q1 2025: $16.04 million | Q2 2025: $13.70 million | Q3 2025: $14.63 million.
- Over the full 16 years of available data (2010 to 2025), Cellectar Biosciences, Inc.'s Total Assets has grown by 211.9%.
- Historical annual values: Fiscal year 2025: $14.98 million | Fiscal year 2024: $25.47 million | Fiscal year 2023: $12.08 million | Fiscal year 2022: $21.59 million | Fiscal year 2021: $37.20 million | Fiscal year 2020: $58.66 million | Fiscal year 2019: $12.25 million | Fiscal year 2018: $15.05 million | Fiscal year 2017: $12.87 million | Fiscal year 2016: $15.32 million | Fiscal year 2015: $7.60 million | Fiscal year 2014: $13.42 million | Fiscal year 2013: $6.82 million | Fiscal year 2012: $11.48 million | Fiscal year 2011: $10.56 million | Fiscal year 2010: $4.80 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: